A detailed history of Polaris Wealth Advisory Group, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Polaris Wealth Advisory Group, LLC holds 2,332 shares of UTHR stock, worth $847,099. This represents 0.04% of its overall portfolio holdings.

Number of Shares
2,332
Holding current value
$847,099
% of portfolio
0.04%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 11, 2023

BUY
$211.82 - $248.24 $493,964 - $578,895
2,332 New
2,332 $526,000
Q1 2021

Apr 19, 2021

BUY
$153.94 - $174.85 $358,988 - $407,750
2,332 New
2,332 $474,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Polaris Wealth Advisory Group, LLC Portfolio

Follow Polaris Wealth Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Polaris Wealth Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Polaris Wealth Advisory Group, LLC with notifications on news.